“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Ampicillin inhibits bacterial cell wall synthesis by binding to 1 or more of the penicillin-binding proteins (PBPs) which in turn inhibit the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.
Ampicillin is indicated in the treatment of infections caused by susceptible strains of the designated organism listed below:
Bacteriology studies to determine the causative organisms and their sensetivity to ampicillin should be performed. Therapy may be instituted prior to the results of susceptibility testing.
Intra-articular:
Supplement in systemic therapy for treatment of susceptible infections-
Intraperitoneal:
Supplement in systemic therapy for treatment of susceptible infections-
Intrapleural:
Supplement in systemic therapy for treatment of susceptible infections-
Intravenous:
Meningitis-
Intrapartum prophylaxis against group B Streptoccocal infection in neonates-
Oral:
Biliary tract infections, Bronchitis, Endocarditis, Gastroenteritis, Listeriosis, Otitis media, Perinatal streptococcal infections, Peritonitis-
Typhoid and paratyphoid fever-
Uncomplicated gonorrhoea-
Urinary tract infections-
Parenteral:
Susceptible infections-
Septicaemia-
Should be taken on an empty stomach. Take 1 hr before or 2 hr after meals.
Hypersensitivity to ampicillin and other penicillins.
Nausea, vomiting, diarrhoea, erythematous maculo-papular rashes, sore mouth, black/hairy tongue, rash, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, fever, joint pains, serum sickness-like symptoms, haemolytic anaemia, thrombocytopenia, leucopenia, neutropenia, coagulation disorders, prolonged bleeding time and prothrombin time, CNS toxicity (e.g. convulsions); paraesthesia, nephropathy, interstitial nephritis, hepatitis, cholestatic jaundice, moderate and transient increase in transaminases, Anaphylaxis, Clostridium difficile-associated diarrhoea (CDAD).
Overdose Effects
Symptoms: Nausea, vomiting and diarrhoea.
Management: Symptomatic and supportive treatment. May be removed from the circulation by haemodialysis.
Pregnancy & Lactation
Pregnancy Category B. Either animal-reproduction studies have not demonstrated a fetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).
Precautions & Warnings
Patient with history of β-lactam allergy. During renal impairment, Pregnancy and lactation.
Use in Special Populations
Renal Impairment: CrCl<10: Dose reduction or increase in dose interval.